D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients

References

• Navi BB, Reiner AS, Kamel H, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2015;77(2):291–300.
   PubMed Web of Science ®Google Scholar
• Stefan O, Vera N, Otto B, et al. Stroke in cancer patients: a risk factor analysis. J Neurooncol. 2009;94(2):221–226.
   PubMed Web of Science ®Google Scholar
• Selvik HA, Thomassen L, Logallo N, et al. Prior cancer in patients with ischemic stroke: the Bergen NORSTROKE study. J Stroke Cerebrovascular Dis. 2014;23(5):919–925.
   PubMed Web of Science ®Google Scholar
• Lau KK, Wong YK, Teo KC, et al. Stroke patients with a past history of cancer are at increased risk of recurrent stroke and cardiovascular mortality. PloS One. 2014;9(2):e88283.
   PubMed Web of Science ®Google Scholar
• Karlinska AG, Gromadzka G, Karlinski MA, et al. The activity of malignancy may determine stroke pattern in cancer patients. J Stroke Cerebrovascular Dis. 2015;24(4):778–783.
   PubMed Web of Science ®Google Scholar
• Aarnio K, Joensuu H, Haapaniemi E, et al. Cancer in young adults with ischemic stroke. Stroke. 2015;46(6):1601–1606.
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Malik AA, Saeed O, et al. Incident cancer in a cohort of 3,247 cancer diagnosis free ischemic stroke patients. Cerebrovasc Dis. 2015;39(5–6):262–268.
   PubMed Web of Science ®Google Scholar
• Quintas S, Rogado J, Gullon P, et al. Predictors of unknown cancer in patients with ischemic stroke. J Neurooncol. 2018.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park JH, Lee MJ, et al. Clues to occult cancer in patients with ischemic stroke. PloS One. 2012;7(9):e44959.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Cordato D, Shen Q, et al. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis. 2007;23(2–3):181–187.
   PubMed Web of Science ®Google Scholar
• Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovascular Dis. 2008;17(4):169–174.
   PubMedGoogle Scholar
• Schwarzbach CJ, Schaefer A, Ebert A, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43(11):3029–3034.
   PubMed Web of Science ®Google Scholar
• Kim JM, Jung KH, Park KH, et al. Clinical manifestation of cancer related stroke: retrospective case-control study. J Neurooncol. 2013;111(3):295–301.
   PubMed Web of Science ®Google Scholar
• Navi BB, Singer S, Merkler AE, et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology. 2014;83(1):26–33.
   PubMed Web of Science ®Google Scholar
• Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62(11):2025–2030.
   PubMed Web of Science ®Google Scholar
• Guo YJ, Chang MH, Chen PL, et al. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovascular Dis. 2014;23(4):e249–e254.
   PubMed Web of Science ®Google Scholar
• Kneihsl M, Enzinger C, Wunsch G, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263(1):150–156.
   PubMed Web of Science ®Google Scholar
• Sanossian N, Djabiras C, Mack WJ, et al. Trends in cancer diagnoses among inpatients hospitalized with stroke. J Stroke Cerebrovascular Dis. 2013;22(7):1146–1150.
   PubMed Web of Science ®Google Scholar
• Kono T, Ohtsuki T, Hosomi N, et al. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Geriatr Gerontol Int. 2012;12(3):468–474.
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke. 1994;25(6):1215–1218.
   PubMed Web of Science ®Google Scholar
• Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol. 2010;68(2):213–219.
   PubMed Web of Science ®Google Scholar
• Dirix LY, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86(3):389–395.
   PubMed Web of Science ®Google Scholar
• Roh JK, Kang DW, Lee SH, et al. Significance of acute multiple brain infarction on diffusion-weighted imaging. Stroke. 2000;31(3):688–694.
   PubMed Web of Science ®Google Scholar
• Wen HM, Lam WW, Rainer T, et al. Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke. Neurology. 2004;63(7):1317–1319.
   PubMed Web of Science ®Google Scholar
• Uemura J, Kimura K, Sibazaki K, et al. Acute stroke patients have occult malignancy more often than expected. Eur Neurol. 2010;64(3):140–144.
   PubMed Web of Science ®Google Scholar
• Chen PC, Muo CH, Lee YT, et al. Lung cancer and incidence of stroke: a population-based cohort study. Stroke. 2011;42(11):3034–3039.
   PubMed Web of Science ®Google Scholar
• Zoller B, Ji J, Sundquist J, et al. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(12):1875–1883.
   PubMed Web of Science ®Google Scholar
• Kim SG, Hong JM, Kim HY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798–801.
   PubMed Web of Science ®Google Scholar
• Murthy SB, Karanth S, Shah S, et al. Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke. 2013;44(12):3573–3576.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zeng J, Xie X, et al. Clinical features of systemic cancer patients with acute cerebral infarction and its underlying pathogenesis. Int J Clin Exp Med. 2015;8(3):4455–4463.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Lavallee PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533–1542.
   PubMed Web of Science ®Google Scholar
• Schwarzbach CJ, Fatar M, Eisele P, et al. DWI lesion patterns in cancer-related stroke–specifying the phenotype. Cerebrovasc Dis Extra. 2015;5(3):139–145.
   PubMed Web of Science ®Google Scholar
• Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer. 2010;102(Suppl 1):S2–S9.
   PubMed Web of Science ®Google Scholar
• Nam KW, Kim CK, Kim TJ, et al. Intravenous thrombolysis in acute ischemic stroke with active cancer. Biomed Res Int. 2017;2017:4635829.
   PubMed Web of Science ®Google Scholar
• Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146–153.
   PubMed Web of Science ®Google Scholar
• Navi BB, Marshall RS, Bobrow D, et al. Enoxaparin vs aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial. JAMA Neurol. 2018;75(3):379–381.
   Web of Science ®Google Scholar